dc.contributor.author |
Schumacher, Max |
|
dc.contributor.author |
Beer, Sina |
|
dc.contributor.author |
Korkmaz, Fulya |
|
dc.contributor.author |
Keppeler, Hildegard |
|
dc.contributor.author |
Fitzel, Rahel |
|
dc.contributor.author |
Erkner, Estelle |
|
dc.contributor.author |
Lengerke, Claudia |
|
dc.contributor.author |
Schneidawind, Corina |
|
dc.contributor.author |
Hoefert, Sebastian |
|
dc.contributor.author |
Schneidawind, Dominik |
|
dc.contributor.author |
Moraes Ribeiro, Emmanuelle |
|
dc.contributor.author |
Radszuweit, Pia Christin |
|
dc.contributor.author |
Mauz, Paul-Stefan |
|
dc.date.accessioned |
2024-07-01T08:44:01Z |
|
dc.date.available |
2024-07-01T08:44:01Z |
|
dc.date.issued |
2024 |
|
dc.identifier.issn |
2234-943X |
|
dc.identifier.uri |
http://hdl.handle.net/10900/154607 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Lausanne : Frontiers Media Sa |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.3389/fonc.2024.1333640 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Treatment response of advanced HNSCC towards immune checkpoint inhibition is associated with an activated effector memory T cell phenotype |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20240422000000_00293 |
|
utue.personen.roh |
Schumacher, Max |
|
utue.personen.roh |
Beer, Sina |
|
utue.personen.roh |
Ribeiro, Emmanuelle Moraes |
|
utue.personen.roh |
Korkmaz, Fulya |
|
utue.personen.roh |
Keppeler, Hildegard |
|
utue.personen.roh |
Fitzel, Rahel |
|
utue.personen.roh |
Erkner, Estelle |
|
utue.personen.roh |
Radszuweit, Pia |
|
utue.personen.roh |
Lengerke, Claudia |
|
utue.personen.roh |
Schneidawind, Corina |
|
utue.personen.roh |
Hoefert, Sebastian |
|
utue.personen.roh |
Mauz, Paul Stefan |
|
utue.personen.roh |
Schneidawind, Dominik |
|
dcterms.isPartOf.ZSTitelID |
Frontiers in Oncology |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 1333640 |
de_DE |
dcterms.isPartOf.ZS-Volume |
14 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |